Vertex partners with Orna to advance In vivo gene therapies for blood disorders
USA—Vertex Pharmaceuticals and Orna Therapeutics have entered into a three-year collaboration to...
Read MoreSelect Page
Jan 13, 2025
USA—Vertex Pharmaceuticals and Orna Therapeutics have entered into a three-year collaboration to...
Read MoreJan 9, 2025
SWITZERLAND—The World Health Organization (WHO) has recently prequalified the first diagnostic...
Read MoreJan 8, 2025
UAE—IROS, an Abu Dhabi-based contract research organization has partnered with Halia Therapeutics,...
Read MoreJan 7, 2025
RWANDA —The Rwanda Biomedical Centre (RBC) has announced plans to deploy two new anti-malaria...
Read MoreJan 6, 2025
LIBERIA—Fifty Liberian professionals have successfully completed a month-long AVoHC-SURGE training...
Read MoreJan 6, 2025
UAE—The Abu Dhabi Stem Cells Center (ADSCC) has made an innovative achievement by successfully...
Read MoreDec 11, 2024
SAUDI ARABIA—The “CPHI Middle East” Global Pharma Exhibition, a premier event for the...
Read MoreDec 10, 2024
USA—Cleerly, a leader in advanced cardiovascular imaging, has successfully raised $106 million in...
Read MoreDec 10, 2024
TANZANIA— The Kibong’oto Infectious Diseases Hospital (KIDH) in Siha, located in the Kilimanjaro...
Read MoreDec 1, 2024
SAUDI ARABIA—Saudi German Health (SGH) has successfully concluded the second edition of its...
Read More